FTC sues big pharmacy benefit managers over insulin prices The company introduced action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of life-preserving insulin medications. Sanders quickly condemned the transfer in a statement Wednesday, noting he was upset although https://aya-healthcare-address72727.blogdal.com/31042618/5-essential-elements-for-healthcare-news